
What taking an antihistamine does to your brain
However, research suggests that the common drugs could be harmful for our brain health. Despite conflicting evidence on just how much of a risk they may pose, one Harvard professor recently confessed that he 'thinks twice about taking antihistamines' as 'theoretically, these drugs might increase the risk of dementia by blocking a particular brain neurotransmitter'.
People who take antihistamines to manage their allergy symptoms shouldn't be alarmed, however, says Dr Adrian Morris, a consultant allergist at the Surrey Allergy Clinic.
'They shouldn't stop taking the drugs and be left struggling away with terrible symptoms because they're too terrified of taking these drugs,' he says. However, it's worth being aware of the potential risk.
What are they and how do they work?
'Antihistamines are drugs used against allergies,' says Dr Morris.
The immune system releases histamine to protect against infections but, in people with allergies, the immune system overreacts and releases histamine in response to a supposed threat – such as pollen, animal hair or dust – when it doesn't need to.
Histamine causes the blood vessels to dilate (which fuels inflammation in the skin, throat and nose), acts on the nerves to trigger sneezing and itchy skin and triggers the glands to make mucus, causing the nose to run and the chest to get phlegmy, Dr Morris explains.
Antihistamines can prevent this reaction, if taken before coming into contact with a substance you're allergic to, or reduce symptoms if you take them afterwards.
How antihistamines affect your brain
Some antihistamines can cross the blood-brain barrier – a membrane that's supposed to protect harmful substances from getting in, Dr Morris explains.
Older versions of antihistamines such as chlorphenamine, known as a first-generation antihistamines, are known to cross into the brain, while the newer, second generation antihistamines are less likely to, though it's still possible for them to accumulate in the organ, he says.
In the brain, antihistamines can block neurotransmitters (chemical messengers), including acetylcholine which is needed for learning and memory. They can also increase brain inflammation. 'This has the net effect of increasing the risk of dementia,' Dr Morris says.
It is known that people with Alzheimer's disease are known to lack acetylcholine and some research suggests that daily use of chlorphenamine for more than three years increases the risk of dementia – though other papers have not found this effect.
'It's not a clear cut difference but the more sedating an antihistamine is, the more it is going into the brain and could be a problem, especially if you take the drug for years on end,' Dr Morris says.
How to know which one to take
A wide range of antihistamines are available over the counter and contain varying active ingredients, explains Claire Nevinson, a superintendent pharmacist at Boots UK.
'These are divided into two groups based on the active ingredient – antihistamines that may cause drowsiness, which include the active ingredient chlorphenamine, and antihistamines that are less likely to cause drowsiness, which include cetirizine, fexofenadine, acrivastine and loratadine,' she says.
'The general rule now is to go for the second generation, non-sedating antihistamines and leave the older ones out of the equation,' Dr Morris says.
This is because, as well as causing drowsiness, the first generation pills are more likely to dilate the blood vessels, which can cause blood pressure to come down and trigger headaches and dizziness, he explains.
These sedating antihistamines can also cause dry mouth, blurred vision, difficulty urinating and constipation, Dr Morris says. They also only work for around four hours, while the newer drugs last for 24 hours, he notes.
It raises the question of why people still take the first generation antihistamines. 'Some people take them to help them to sleep at night,' he says. As they have a sedating effect, they can also help with feeling less nervous or anxious, which some people like, Dr Morris notes.
When it comes to choosing which second-generation antihistamine to take, cetirizine, loratadine and fexofenadine are the main ones that are recommended, he says.
Which one patients choose is personal preference but it can be helpful to change the drug they're taking every few months.
'What happens is tachyphylaxis – when you take a medication and it becomes less effective because the body becomes more tolerant to it,' Dr Morris says. 'I recommend patients to take one drug for a few months and then change as the drugs will work better.
'There's little evidence to suggest one antihistamine is better than any other at relieving allergy symptoms,' though the second generation drugs are less likely to have side effects that interfere with daily life, Nevinson says.
'There are a range of products available for hay fever relief and if you are ever unsure on how to best manage your hay fever symptoms, speak to your pharmacist who may be able to help,' she adds.
Other uses of antihistamines
Insect bites and stings
Insect bites and stings can trigger the body's immune system to release histamine, which in turn causes swelling and itchiness at the site of the bite. Antihistamines can ease this reaction, making bites less irritating.
Itchy skin
'As you get older, your skin gets drier and often it starts to itch, especially among men,' Dr Morris says. A daily antihistamine can relieve itching for these patients, he says.
Travel sickness
A first generation antihistamine, called cinnarizine, is known to improve blood flow to the inner ear, which can reduce feelings of nausea and dizziness caused by travel sickness.
Verdict: Should I take antihistamines?
The research that has found a link between antihistamines and dementia isn't perfect and it doesn't suggest that 'everyone who takes antihistamines for six months is going to end up with dementia,' Dr Morris says.
'We don't have any high-quality, long-term studies – we've got to watch people over their entire lifetime [to properly determine the risk],' he notes.
'I would say that the second generation is preferable to the first generation, and if an antihistamine makes you feel tired and lethargic, or sedates you, then maybe choose another one that you don't find sedating,' he says, 'as it's probably crossing the blood-brain barrier much less.'
FAQs
What happens if you take too many antihistamine pills?
'If you accidentally take too many antihistamines, you should seek medical help, taking the medicine packet with you so that a healthcare professional can see which type of antihistamine you've taken,' Nevinson says.
However, Dr Morris says there is no risk from accidentally taking two or three antihistamine pills, instead of the usually recommended one pill, because the drugs are non-toxic.
Can you drink alcohol while taking antihistamines?
'It is recommended not to drink alcohol whilst taking an antihistamine, particularly if it's a type that makes you drowsy,' Nevinson says.
'Doing so can increase the chances of feeling drowsy and reduce co-ordination, reaction speed and judgement. Most foods and other drinks don't tend to affect most antihistamines, however always read the leaflet that comes with your medicine to make sure.'
Can you take antihistamines alongside ibuprofen and paracetamol?
'There are currently no known interactions between antihistamines being taken alongside ibuprofen or paracetamol,' Nevinson says.
'However, it is important to speak to your pharmacist before taking any new medicines available over the counter to check for suitability.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
15 hours ago
- Daily Mirror
Cats with dementia could help develop Alzheimer's treatment says study
The brains of cats with dementia undergo similar changes to those in people with Alzheimer's, according to a new Scottish study Research has discovered that cats affected by dementia undergo similar changes in their brain to humans with Alzheimer's disease. These parallels could mark a new way of studying the condition and potentially finding a treatment say experts at the University of Edinburgh. The discovery not only provides fresh hope for tackling Alzheimer's in humans, but also offers the potential that cutting-edge therapies developed for people might eventually also help our elderly feline companions too. Traditionally, researchers have depended on genetically altered rodents for Alzheimer's studies. However, rodents don't develop dementia naturally the way humans and cats do. Cats also exhibit similar symptoms to humans, including heightened vocalisation, confusion and disturbed sleeping habits. Dr Robert McGeachan, the study's principal investigator from the Royal (Dick) School of Veterinary Studies, said: "Dementia is a devastating disease - whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. "This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers." The study examined the brains of 25 dead cats of various ages. It found those with dementia had a build-up of amyloid-beta in their synapses, mirroring the build-up seen in humans with Alzheimer's disease. The findings, published in the European Journal of Neuroscience, could shed light on the mechanisms behind this accumulation and its role in cognitive decline and brain dysfunction. Researchers noted in the cat brains that support cells appeared to be 'eating' away at the damaged synapses. This phenomenon is known as synaptic pruning. While synaptic pruning is essential for healthy brain development, it may also contribute to the synaptic damage associated with dementia. Professor Danièlle Gunn-Moore from the Royal (Dick) School of Veterinary Studies said: "Feline dementia is so distressing for the cat and for its person. It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. Feline dementia is the perfect natural model for Alzheimer's, everyone benefits." The research was a collaborative effort involving experts from the Universities of Edinburgh and California, the UK Dementia Research Institute, and Scottish Brain Sciences, with backing from Wellcome and the UK Dementia Research Institute.

Leader Live
2 days ago
- Leader Live
Cats develop dementia similarly to humans
Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

Rhyl Journal
2 days ago
- Rhyl Journal
Cats develop dementia similarly to humans
Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'